DIA: Driving Insights to Action
Science:Life Sciences
Dr. Robert Nelson is Senior Director, Pediatric Product Development, for Johnson & Johnson, and previously served as Deputy Director and Senior Pediatric Ethicist in the FDA Office of Pediatric Therapeutics. At the DIA 2018 Global Annual Meeting, Dr. Nelson led discussions about “Regulatory and Ethical Considerations with Placebo Administration Using a Central Venous Access Device in a Clinical Trial” which is investigating therapies for a pediatric rare disease. Watch the video of this podcast interview.
More Episodes
Medication Errors Emerge as Global Patient Safety Issue
2022-07-28
486
2022-07-28
486
What We Are Missing by Not Including ”Who?”
2022-06-30
456
2022-06-30
456
Cancer Data Ecosystem Powering Moonshot Relaunch
2022-05-18
420
2022-05-18
420
Complexity Continues to Challenge Clinical Costs
2022-05-02
391
2022-05-02
391
Maximizing Regulatory Resources Across Latin America
2022-04-25
421
2022-04-25
421
Innovation Without Access Will Never Meet Patient Needs
2021-12-14
458
2021-12-14
458
Telehealth Emerging in Japan’s Clinical Research and Care
2021-09-27
560
2021-09-27
560
Early Access Programs Complicating Comparative Data Analyses
2021-08-25
519
2021-08-25
519
eLabeling More than Moving from Paper to Digital
2021-08-02
585
2021-08-02
585
Australia: Growing Clinical Trials Even in Pandemic’s Wake
2021-05-11
474
2021-05-11
474
Remote Tools Keep Japan's Research Moving
2021-04-26
439
2021-04-26
439
Get this podcast on your
phone, FREE
